- Home
- IRTC
as 11-24-2025 11:01am EST
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Francisco |
| Market Cap: | 5.8B | IPO Year: | 2016 |
| Target Price: | $199.79 | AVG Volume (30 days): | 573.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.62 | EPS Growth: | N/A |
| 52 Week Low/High: | $71.00 - $212.00 | Next Earning Date: | 10-30-2025 |
| Revenue: | $702,573,000 | Revenue Growth: | 25.45% |
| Revenue Growth (this year): | 26.74% | Revenue Growth (next year): | 17.00% |
Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TALWALKAR ABHIJIT Y | IRTC | Director | Nov 10 '25 | Sell | $174.71 | 5,312 | $924,961.65 | 21,025 | |
| Blackford Quentin S. | IRTC | President and CEO | Nov 3 '25 | Sell | $182.94 | 14,059 | $2,571,907.07 | 164,979 | |
| Wilson Daniel G. | IRTC | Chief Financial Officer | Oct 31 '25 | Sell | $207.44 | 8,000 | $1,659,520.00 | 26,470 | |
| Wilson Daniel G. | IRTC | Chief Financial Officer | Sep 3 '25 | Sell | $175.00 | 5,000 | $875,000.00 | 26,470 | |
| Wilson Daniel G. | IRTC | Chief Financial Officer | Sep 2 '25 | Sell | $167.28 | 737 | $123,285.36 | 26,470 |
Latest iRhythm Technologies Inc. News
IRTC Breaking Stock News: Dive into IRTC Ticker-Specific Updates for Smart Investing
Insider Monkey
a month ago
iRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates Coverage
GlobeNewswire
a month ago
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
Simply Wall St.
2 months ago
Why Analysts Are Rethinking the Growth Story for iRhythm Technologies After Recent Industry Shifts
Simply Wall St.
2 months ago
How Regulatory and Legal Hurdles Will Impact iRhythm Technologies (IRTC) Investors
StockStory
2 months ago
2 Healthcare Stocks to Research Further and 1 Facing Challenges
StockStory
2 months ago
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
StockStory
2 months ago
1 Cash-Producing Stock with Competitive Advantages and 2 We Question
Insider Monkey
2 months ago
iRhythm Technologies, Inc. (IRTC) Shares Surge 96% Despite FDA Warning and Legal Challenges
Compare IRTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.